Literature DB >> 32006931

Combined DCE-MRI- and FDG-PET enable histopathological grading prediction in a rat model of hepatocellular carcinoma.

Georgios A Kaissis1, Fabian K Lohöfer1, Marie Hörl1, Irina Heid1, Katja Steiger2, Kim Agnes Munoz-Alvarez3, Markus Schwaiger3, Ernst J Rummeny1, Wilko Weichert2, Philipp Paprottka1, Rickmer Braren4.   

Abstract

PURPOSE: To test combined dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and 18F-FDG positron emission tomography (FDG-PET)-derived parameters for prediction of histopathological grading in a rat Diethyl Nitrosamine (DEN)-induced hepatocellular carcinoma (HCC) model.
METHODS: 15 male Wistar rats, aged 10 weeks were treated with oral DEN 0.01 % in drinking water and monitored until HCCs were detectable. DCE-MRI and PET were performed consecutively on small animal scanners. 38 tumors were identified and manually segmented based on HCC-specific contrast enhancement patterns. Grading (G2/3: 24 tumors, G1:14 tumors) alongside other histopathological parameters, tumor volume, contrast agent and 18F-FDG uptake metrics were noted. Class imbalance was addressed using SMOTE and collinearity was removed using hierarchical clustering and principal component analysis. A logistic regression model was fit separately to the individual parameter groups (DCE-MRI-derived, PET-derived, tumor volume) and the combined parameters.
RESULTS: The combined model using all imaging-derived parameters achieved a mean ± STD sensitivity of 0.88 ± 0.16, specificity of 0.70 ± 0.20 and AUC of 0.90 ± 0.03. No correlation was found between tumor grading and tumor volume, morphology, necrosis, extracellular matrix, immune cell infiltration or underlying liver fibrosis.
CONCLUSION: A combination of DCE-MRI- and 18F-FDG-PET-derived parameters provides high accuracy for histopathological grading of hepatocellular carcinoma in a relevant translational model system.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DCE-MRI; FDG-PET; Hepatocellular carcinoma; Preclinical models; Tumour grading

Mesh:

Substances:

Year:  2020        PMID: 32006931     DOI: 10.1016/j.ejrad.2020.108848

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

1.  Preoperative determination of pathological grades of primary single HCC: development and validation of a scoring model.

Authors:  Zhao-Xiang Ye; Wen Shen; Kun Zhang; Wen-Cui Li; Shuang-Shuang Xie; Li-Ying Lin; Zhi-Wei Shen
Journal:  Abdom Radiol (NY)       Date:  2022-07-17

2.  Early Diagnosis Value of DCE-MRI Hemodynamic Parameters in Hepatocellular Carcinoma.

Authors:  Xixi Mu; Yue Zhong; Xuan Zhang; Changjun Qu
Journal:  J Oncol       Date:  2022-05-13       Impact factor: 4.501

Review 3.  Radiomics for the detection of microvascular invasion in hepatocellular carcinoma.

Authors:  Kun Lv; Xin Cao; Peng Du; Jun-Yan Fu; Dao-Ying Geng; Jun Zhang
Journal:  World J Gastroenterol       Date:  2022-05-28       Impact factor: 5.374

4.  Hyperpolarized 13C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC.

Authors:  Elisabeth Bliemsrieder; Georgios Kaissis; Martin Grashei; Geoffrey Topping; Jennifer Altomonte; Christian Hundshammer; Fabian Lohöfer; Irina Heid; Dominik Keim; Selamawit Gebrekidan; Marija Trajkovic-Arsic; A M Winkelkotte; Katja Steiger; Roman Nawroth; Jens Siveke; Markus Schwaiger; Marcus Makowski; Franz Schilling; Rickmer Braren
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.